Evidence map›Paper›PMID 34997893›Full record

ArticleGlycoconjugate journal2021

The association between serum interleukin-1 beta and heparin sulphate in diabetic nephropathy patients.

Liqiong Jiang, Jianying Zhou, Li Zhang, Yufeng Du, Mingming Jiang, Liqian Xie, Zhenni Ma, Fengling Chen

Open access · hybridAbstract read
In one paragraph

Article in Glycoconjugate journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Role of Interleukins in Type 1 and Type 2 Diabetes.Diagnostics (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Liqiong JiangDepartment of Nephrology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China. 98qiong2008@163.com.ORCID http://orcid.org/0000-0003-2104-6238
Jianying ZhouDepartment of Endocrinology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Li ZhangClinical Lab, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Yufeng DuDepartment of Nephrology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Mingming JiangDepartment of Nephrology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Liqian XieJiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Zhenni MaJiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Fengling ChenDepartment of Hemodialysis Center, the First Affiliated Hospital of Soochow University, Suzhou, China. cfl95002@163.com.
Suzhou Municipal Hospital · CNSoochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is considered an important mechanism in the development of diabetes mellitus (DM) and persists for a long time before the occurrence of diabetic nephropathy (DN). Many studies have demonstrated that a decrease in the endothelial glycocalyx (EG) is negatively correlated with proteinuria. To elucidate whether EG damage induced by inflammasomes in DM patients leads to the occurrence of microalbuminuria (MA) and accelerates the progression of DN, this study screened 300 diagnosed DM patients. Finally, 70 type 2 diabetes patients were invited to participate in this study and were divided into two groups: the T2DM group (patients with normal MA and without diabetic retinopathy, n = 35) and the T2DN group (patients with increased MA and diabetic retinopathy, n = 35). Circulating heparin sulphate (HS, EG biomarkers) and interleukin-1 beta (IL-1β, inflammasome biomarkers) of the patients were measured by ELISA. Laboratory data were measured using routine laboratory methods. Patients in the T2DN group had increased serum HS, increased IL-1β, increased CRP, decreased haemoglobin, and increased neutrophils compared to patients in the T2DM group (all P < 0.05). Increased HS and decreased haemoglobin were independently associated with T2DN patients. ROC curves showed that the AUC of HS for the prediction of T2DN was 0.67 (P < 0.05). The combination of HS and haemoglobin yielded a significant increasement in the AUC (0.75, P < 0.001) with optimal sensitivity (71.2%) and specificity (79%). Furthermore, serum IL-1β was positively correlated with HS and was an independent associated factor of HS in the T2DN group. The relationship between HS and IL-1β was not significant in the T2DM group. Our findings surgessed the inflammasome may be associated with and promote damage to the EG during the disease course of DN that manifests as increased MA.

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesBiomarkersHeparinHumansInterleukin-1betaSulfatesBiomarkersHeparinInterleukin-1betaSulfatesDiabetic nephropathyEndothelial glycocalyxheparin sulphateInflammasomeInterleukin 1βMicroalbuminuria

Identifiers

PMID34997893
PMCPMC8821487
OpenAlexW4206651584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.